Ryan T Gill

This inventor holds 69 USPTO granted patents and 37 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Genome Editing (CPC class C12N). Top assignees: Inscripta, Inc., University of Colorado, Biota Technology, Inc.. Active years: 2010-2026.

USPTO Granted Patents = 69 (Patent Applications = 37)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 20)

Average Co-Inventor Count = 3.2

ph-index = 20

Forward Citations = 1,330(Granted Patents)

Forward Citations (Not Self Cited) = 996(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Boulder, CO (US) (2010 - 2023)
Denver, CO (US) (2010 - 2024)

Company Filing History:

University of Colorado

patents

6 out of 6

Biota Technology, Inc.

Celyntra Therapeutics Sa

patents

6. 2 out of 292

Technical University of Denmark

patents

7. 1 out of 4

Opx Biotechnologies, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

CRISPR

Genome Editing

Nucleic Acids

Automated Cell Processing

Microbiome Systems

Barcoded Libraries

Nucleases

Multiplexed Engineering

Hydrocarbon Production

Genome Engineering

Combinatorial Libraries

Bacterial Populations

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12529076 - CRISPR SYSTEMS WITH ENGINEERED DUAL GUIDE NUCLEIC ACIDS (2026-01-20),

2. 12270044 - CRISPR systems with engineered dual guide nucleic acids (2025-04-08),

3. 12195749 - Nucleic acid-guided nucleases (2025-01-14),

4. 12180502 - Nucleic acid-guided nucleases (2024-12-31),

5. 12145962 - Construction and methods of use of a barcoded and gene edited DNA library (2024-11-19),

6. 12065678 - Constructs, compositions and methods thereof having improved genome editing efficiency and specificity (2024-08-20),

7. 11795479 - CRISPR enabled multiplexed genome engineering (2023-10-24),

8. 11702677 - CRISPR enabled multiplexed genome engineering (2023-07-18),

9. 11697826 - Nucleic acid-guided nucleases (2023-07-11),

10. 11639511 - CRISPR enabled multiplexed genome engineering (2023-05-02),

11. 11629593 - Microbiome based systems, apparatus and methods for the exploration and production of hydrocarbons (2023-04-18),

12. 11597921 - Automated cell processing methods, modules, instruments, and systems (2023-03-07),

13. 11584928 - Methods for generating barcoded combinatorial libraries (2023-02-21),

14. 11408012 - Nucleic acid-guided nucleases (2022-08-09),

15. 11345933 - CRISPR enabled multiplexed genome engineering (2022-05-31),

Title: The Innovative Journey of Ryan T Gill

Introduction: Ryan T Gill is a pioneering inventor based in Denver, Colorado, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Ryan T Gill holds several patents in various industries, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: With a career marked by innovation and forward thinking, Ryan T Gill has consistently pushed the boundaries of what is possible. His work has not only revolutionized industries but has also inspired a new generation of inventors.

Collaborations: Throughout his career, Ryan T Gill has collaborated with leading experts and organizations to bring his ideas to life. These partnerships have been instrumental in the success of his inventions and have paved the way for future innovations.

Conclusion: Ryan T Gill's impact on the world of inventions and technology is undeniable. His relentless pursuit of innovation and his ability to think outside the box have solidified his place as a true trailblazer in the field.